Entrada Therapeutics
TRDA
#9077
Rank
HK$1.33 B
Marketcap
HK$34.10
Share price
-6.25%
Change (1 day)
-56.66%
Change (1 year)

P/S ratio for Entrada Therapeutics (TRDA)

P/S ratio as of November 2026 (TTM): 36.7

According to Entrada Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.7363. At the end of 2026 the company had a P/S ratio of 64.1.

P/S ratio history for Entrada Therapeutics from 2021 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202664.1324.37%
202515.1388.86%
20243.09-20.81%
20233.90
2022N/A
2021N/A